PURPOSE: The impact of prophylactic supplementation of N-acetyl-cysteine (NAC) and epigallocatechin gallate (EGCG) on intramuscular expression of proteolytic genes after unaccustomed eccentric muscle contractions was investigated. METHODS:Thirty apparently healthy males (mean ± SD: 20.0 ± 1.8 years, 175 ± 7.1cm, 76.1 ± 16.9 kg) ingested daily either 1,800 mg ofNAC or 1,800 mg of EGCG (98% total polyphenols, 80% total catechins, and 50% EGCG), or 1,000 mg of a glucomannan placebo (PLA) in a double blind, prophylactic fashion for 14 days. Subjects then completed an unaccustomed eccentric exercise bout (100 repetitions at 30 °s(-1)) using the dominant knee extensors. Skeletal muscle biopsies were collected from the vastus lateralis at baseline and both 6 and 24h after exercise. The expression of proteolytic genes [i.e., muscle ring-finger 1 (MuRF1), atrogin-1, α-type 20S subunit C2 (HC2), α-type 20S subunit C3 (HC3), ubiquitin protein ligase 3B (UBE3B), μ-calpain, and m-calpain] was quantified using real-time RT-PCR. Separate 3 × 3 (group × time) repeated measures ANOVAs were used to analyze changes in gene expression over time between groups. RESULTS: No significant group × time interactions were detected between groups for the expression of any of the atrogenes or calpains (p>0.05). Significant main effects for time identified increases in MuRF1 (6h: 5.3 ± 10.8 fold; p=0.046), UBE3B (6h: 5.3 ± 7.7 fold; p=0.006; 24h: 3.3 ± 4.5 fold; p=0.005), and m-calpain expression (6h: 2.7 ± 4.4 fold; p=0.045) in all participants following exercise. Increases approached significance in HC2 (6h: 1.9 ± 2.4 fold; p=0.079; 24h: 1.6 ± 1.9 fold; p=0.084) and m-calpain expression (24h: 1.8 ± 2.3 fold; p=0.084) following exercise. CONCLUSIONS: Prophylactic supplementation of NAC and EGCG did not impact acute changes in skeletal muscle proteolytic gene expression following eccentric exercise. Eccentric muscle contractions elevated MuRF1 and UBE3B, while m-calpain and HC2 mRNA tended to increase.
RCT Entities:
PURPOSE: The impact of prophylactic supplementation of N-acetyl-cysteine (NAC) and epigallocatechin gallate (EGCG) on intramuscular expression of proteolytic genes after unaccustomed eccentric muscle contractions was investigated. METHODS: Thirty apparently healthy males (mean ± SD: 20.0 ± 1.8 years, 175 ± 7.1cm, 76.1 ± 16.9 kg) ingested daily either 1,800 mg of NAC or 1,800 mg of EGCG (98% total polyphenols, 80% total catechins, and 50% EGCG), or 1,000 mg of a glucomannan placebo (PLA) in a double blind, prophylactic fashion for 14 days. Subjects then completed an unaccustomed eccentric exercise bout (100 repetitions at 30 °s(-1)) using the dominant knee extensors. Skeletal muscle biopsies were collected from the vastus lateralis at baseline and both 6 and 24h after exercise. The expression of proteolytic genes [i.e., muscle ring-finger 1 (MuRF1), atrogin-1, α-type 20S subunit C2 (HC2), α-type 20S subunit C3 (HC3), ubiquitin protein ligase 3B (UBE3B), μ-calpain, and m-calpain] was quantified using real-time RT-PCR. Separate 3 × 3 (group × time) repeated measures ANOVAs were used to analyze changes in gene expression over time between groups. RESULTS: No significant group × time interactions were detected between groups for the expression of any of the atrogenes or calpains (p>0.05). Significant main effects for time identified increases in MuRF1 (6h: 5.3 ± 10.8 fold; p=0.046), UBE3B (6h: 5.3 ± 7.7 fold; p=0.006; 24h: 3.3 ± 4.5 fold; p=0.005), and m-calpain expression (6h: 2.7 ± 4.4 fold; p=0.045) in all participants following exercise. Increases approached significance in HC2 (6h: 1.9 ± 2.4 fold; p=0.079; 24h: 1.6 ± 1.9 fold; p=0.084) and m-calpain expression (24h: 1.8 ± 2.3 fold; p=0.084) following exercise. CONCLUSIONS: Prophylactic supplementation of NAC and EGCG did not impact acute changes in skeletal muscle proteolytic gene expression following eccentric exercise. Eccentric muscle contractions elevated MuRF1 and UBE3B, while m-calpain and HC2 mRNA tended to increase.
Authors: Sara Hayward; Colin D Wilborn; Lem W Taylor; Stacie L Urbina; Jordan J Outlaw; Cliffa A Foster; Michael D Roberts Journal: J Sports Sci Med Date: 2016-12-01 Impact factor: 2.988
Authors: Mackenzie Haines; Sarah K McKinley-Barnard; Thomas L Andre; Josh J Gann; Paul S Hwang; Darryn S Willoughby Journal: J Sports Sci Med Date: 2018-03-01 Impact factor: 2.988
Authors: Ana C Gonçalves; Dário Gaspar; José David Flores-Félix; Amílcar Falcão; Gilberto Alves; Luís R Silva Journal: Int J Mol Sci Date: 2022-04-22 Impact factor: 6.208
Authors: Michael D Roberts; Cody T Haun; Christopher B Mobley; Petey W Mumford; Matthew A Romero; Paul A Roberson; Christopher G Vann; John J McCarthy Journal: Front Physiol Date: 2018-07-04 Impact factor: 4.566
Authors: Yulia N Lomonosova; Boris S Shenkman; Grigorii R Kalamkarov; Tatiana Y Kostrominova; Tatyana L Nemirovskaya Journal: PLoS One Date: 2014-04-15 Impact factor: 3.240